ArticleEuropean urology open science2025
Evaluation of an Antibiotic Strategy for Ureteral Stent Removal After Kidney Transplant.
Article in European urology open science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective: This study evaluates the effectiveness of a urine culture (UC)-guided antibiotic strategy in preventing urinary tract infections (UTIs) following ureteral stent (US) removal in kidney transplant recipients. Methods: This prospective, single-center cohort study included kidney transplant recipients undergoing cystoscopic US removal. A three-phase protocol was implemented: (1) preprocedure UC screening and UC-guided treatment, (2) US removal with UC and a microbiological analysis of the proximal and distal coils, and (3) postprocedure monitoring for UTI development. The primary outcome was UTI incidence within 48 hours and 1 month after the procedure. Key findings and limitations: The study included 137 patients (median age: 55.8 yr, interquartile range: 15.0). Preprocedure UC screening was positive in 19.7% ( Conclusions and clinical implications: A UC-guided approach appears effective in reducing UTIs after US removal in kidney transplant recipients. Patient summary: Implementation of a urine culture-based antibiotic strategy before ureteral stent removal in kidney transplant recipients significantly decreases the incidence of postprocedural urinary tract infections. Additionally, patients with bladder catheters in place for >5 days faced a notably higher risk of stent colonization, emphasizing the importance of timely catheter removal.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.